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Abstract
Renal lithiasis is a multifactorial disease. An important number of etiologic factors can be adequately
modified trough diet, since it must be considered that the urine composition is directly related to
diet. In fact, the change of inappropriate habitual diet patterns should be the main measure to
prevent kidney stones. In this paper, the relation between different dietary factors (liquid intake,
pH, calcium, phosphate, oxalate, citrate, phytate, urate and vitamins) and each type of renal stone
(calcium oxalate monohydrate papillary, calcium oxalate monohydrate unattached, calcium oxalate
dihydrate, calcium oxalate dihydrate/hydroxyapatite, hydroxyapatite, struvite infectious, brushite,
uric acid, calcium oxalate/uric acid and cystine) is discussed.
Introduction
Renal lithiasis can be defined as the consequence of an
alteration of the normal crystallization conditions of
urine in the urinary tract. In a healthy individual, during
the residence time of urine in the urinary tract, crystals
either do not form or are so small they are eliminated une-
ventfully (asymptomatic crystalluria). When normal urine
crystallization conditions become altered, however, the
rate of crystal nucleation and growth may become such
that the crystals cannot be easily eliminated due to their
size. In some cases, altered urinary conditions affecting
crystallization are related to specific underlying disorders
such as hyperparathyroidism, which is associated with
hypercalciuria [1]; tubular acidosis, which is associated
with hypercalciuria and hypocitraturia [2]; and some
genetic alterations, which are associated with hyperoxalu-
ria [3], hypercystinuria [4] and hypercalciuria [5]. How-
ever, in many cases it is not possible to clearly identify the
underlying disorder. Indeed, in nearly all renal calculi
cases, crystal formation is attributable to a combination of
diverse factors that may or may not be associated with an
underlying disorder. These factors can be classified into
two main groups: urine composition factors and renal
morphoanatomy factors.
Urine composition factors are important in crystal forma-
tion as urine is a metastable liquid containing several
coexisting substances that can crystallize to generate renal
calculi. These substances are present at supersaturated lev-
els (the system contains higher amounts of solute than
that corresponding to the solubility), meaning the urine is
in an unstable state, and a stable urine state will eventuate
through crystallization of the excess solute. The ease of
crystallization depends on the degree of supersaturation,
the presence of preformed particles (so-called heterogene-
ous nucleants that act as promoter substances) and the
level of crystallization inhibitors. These latter substances
inhibit crystal nucleation and/or growth.
There are two main renal morphoanatomy factors that
can affect crystal formation. The first of these is the pres-
ence of cavities (formed by renal calices) with low urody-
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namic efficacy that retain urine for long periods. The
second is an altered epithelium covering the renal papil-
lae, which can arise from events such as damage to the
anti-adherent glycosaminoglycan layer that covers the
uroepithelium, necrosis, or the presence of subepithelial
calcifications.
The development of renal calculi usually involves both
urine composition and renal morphoanatomy factors.
Thus, not all people with hypercalciuria, hypocitraturia or
hyperuricuria, for example, will develop renal calculi. The
effect of a factor on renal lithiasis depends on the nature
and magnitude of other factors when a particular renal
stone is generated. For example, while some alterations to
the uroepithelium alone may not be serious enough to
cause stone formation, when combined with other factors
stone formation might occur. Thus, precise knowledge of
the factors involved in the development of a given renal
calculus is vital, and adequate study of the calculus struc-
ture and composition allows identification of an impor-
tant number of possible etiologic factors related to its
formation. Many such factors can be adequately modified
through diet, as this has a significant effect on urine com-
position. Indeed, altering inappropriate habitual dietary
patterns should be the main measure for preventing kid-
ney stones. There are thorough recent literature reviews on
nutrition and renal lithiasis that discuss numerous dietary
factors and their effects on urine composition and stone
formation [6,7].
The present paper discusses the relationship between dif-
ferent dietary factors and each type of renal stone [8],
using the classification indicated in Table 1. A key aspect
in preventing all kinds of kidney stone is suitable liquid
intake, which affects both the urine concentration and the
frequency with which solid microparticles are expelled
from the urinary system. A study of idiopathic calcium
oxalate stone formation demonstrated that the initial
therapy for the prevention of any type of kidney stone
recurrence is increased fluid intake to ensure a urine vol-
ume of at least 2 liters per day [9].
Type of renal stone and dietary advice
Calcium oxalate monohydrate papillary calculi
Formation of calculi of this type implies the existence of
an altered (damaged or partially injured) papillary epithe-
lium. This can be a consequence of cytotoxic substances
that also can induce subepithelial calcifications [10,11].
Moreover, renal calculi of this type are frequently associ-
ated with a deficiency in the levels of crystallization inhib-
itors and hyperoxaluria. Citrate and phytate are the only
crystallization inhibitors that can be taken via the diet or
as a pharmaceutical.
Citrate consumption (through citrate-containing foods or
as potassium or sodium salt drugs) causes an increase in
urinary pH, which results in increased citrate excretion
[12]. In this case, the urinary pH must be controlled to
avoid calcium phosphate crystallization. Citrate decreases
calcium salt supersaturation due to its capacity to complex
calcium ions, and also has crystallization inhibitor activity
[13].
Phytate, mainly present in whole cereals and legumes (see
Table 3), can inhibit calcium salt crystallization [14-17],
and individuals prone to calcium oxalate stone formation
were found to have lower urinary phytate excretion com-
pared to healthy subjects [18]. Data from two large obser-
vational epidemiological studies revealed an inverse
association between phytate intake and the risk of stone
formation in women [19].
Oxalate-rich foods may be a risk factor for formation of
calcium oxalate monohydrate papillary calculi (see Table
4). A dietary oxalate excess is related to formation of cal-
cium oxalate monohydrate (COM) calculi and can mainly
be related to an excess consumption of soybean seeds,
nuts, spinach, chocolate and green tea [20]. However,
there are high intra-individual variations to the contribu-
tion of ingested oxalate to urinary oxalate excretion. The
urinary exogenic oxalate can account from approximately
10% [21] to over 50%, in particular in the presence of
oxalate hyperabsorption or in presence of an adverse cal-
Table 1: Renal stone classification
Renal stone classification [8] Percentage (%)
• Calcium oxalate monohydrate papillary 13
• Calcium oxalate monohydrate unattached (formed in renal cavities) 16
• Calcium oxalate dihydrate 34
• Calcium oxalate dihydrate/hydroxyapatite mixed 11
• Hydroxyapatite 7
• Struvite infectious 4
• Brushite 1
• Uric acid 8
• Calcium oxalate/uric acid mixed 3
• Cystine 1Nutrition Journal 2006, 5:23 http://www.nutritionj.com/content/5/1/23
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cium/oxalate ratio in the gut [22]. Moreover, it is also nec-
essary to consider ascorbic acid (vitamin C), which is an
oxalate precursor. A study involving 186 calcium oxalate
stone formers with and without hyperoxaluria demon-
strated an inverse association between urinary oxalate
excretion and dietary calcium intake, and a positive rela-
tionship with dietary ascorbate [7]. A human study
involving stone formers and non-stone formers who
ingested 2000 mg/day ascorbic acid demonstrated
increased urinary oxalate excretion in 40% of all partici-
pants (both stone formers and non-stone formers) [23].
Calcium oxalate monohydrate unattached calculi (formed 
in renal cavities)
The main etiologic factors for these calculi are the exist-
ence of cavities with low urodynamic efficacy, the pres-
ence of heterogeneous nucleants mainly constituted by
organic matter, hydroxyapatite crystals at a urinary pH ≥
6.0 or uric acid crystals at a urinary pH ≤ 5.5, and a defi-
ciency in the crystallization inhibitors citrate and phytate
[24]. Hyperoxaluria is also a factor frequently associated
with this type of renal calculi [25]. Dietary habits associ-
ated with high oxaluria and crystallization inhibitor defi-
ciency are discussed above and summarized in Table 2.
Urinary pH is an important variable that can be strongly
affected by diet. A diet rich in animal protein is associated
with high uric acid urinary excretion and a low urinary pH
[26,27]. Uric acid solubility decreases dramatically at a
urinary pH lower that 5.5, leading to uric acid crystal for-
mation that can act as a heterogeneous nucleant for cal-
cium oxalate crystals [28]. For people eating a vegetarian
diet, the consumption of citrate-rich products (foods and
soft-drinks) and carbonated beverages notably increases
the urinary pH [26,27,29]. In this case, it is important to
consider that calcium phosphate solubility abruptly
decreases at pH values above 6.0, causing formation of
calcium phosphate crystals that can act as heterogeneous
nucleants for calcium oxalate crystals [30]. Indeed,
hydroxyapatite and uric acid are very frequently found at
the core of renal calculi of this type [8]. The dietary recom-
mendations for urinary pH control are summarized in
Table 2.
Calcium oxalate dihydrate calculi
These calculi generally develop in cavities of low urody-
namic efficacy and are associated with hypercalciuria,
crystallization inhibitor (citrate and phytate) deficiency
and in some cases with urinary pH values greater than 6.0
[8]. Dietary aspects related to crystallization inhibitors
and urinary pH > 6.0 are discussed above and summa-
rized in Table 2. Recent studies demonstrate that an
increase in urinary calcium excretion is mainly associated
with a high consumption of sodium and animal protein
rather than consumption of dietary calcium [17,31]. Con-
sequently, a decrease in the consumption of sodium and
animal protein is recommended for reducing urinary cal-
cium levels. Also excess consumption of Vitamin D with
calcium supplements can induce excessive urinary cal-
cium excretion [30,32]. However, decreasing urinary cal-
cium concentration through restriction of dietary sodium
and animal protein is often not completely effective and
hypercalciuria persists. In such cases, the type of hypercal-
ciuria should be determined and drug treatment may be
necessary [33,34].
Calcium oxalate dihydrate/hydroxyapatite mixed calculi
These calculi are associated with hypercalciuria, a urinary
pH > 6.0, and hypocitraturia [8]. The existence of cavities
with low urodynamic efficacy favours the formation of
these calculi. Dietary aspects related to urinary pH and cal-
cium and citrate excretion are discussed above and sum-
marized in Table 2. In several cases, hypercalciuria
detected in these stone formers is associated with hyper-
parathyroidism that must be treated [1,35].
Hydroxyapatite calculi
The etiologic factors related to these calculi are a urinary
pH > 6.0, hypocitraturia, hypercalciuria, hyperphosphatu-
ria and hypomagnesiuria. Formation of these calculi is
also favoured by the existence of cavities with low urody-
namic efficacy. Dietary aspects related to urinary pH and
calcium and citrate excretion are discussed above and
summarized in Table 2. The urinary phosphate is related
with phosphate intake [36], but as in the case of oxalate,
dietary phosphate restriction increases calcium urinary
excretion [37]. For this reason, the decrease in phosphate
intake (restriction of milk, cheese, fish, sausages, soft
drinks with phosphoric acid) should go in with a calcium
intake reduction [38] and apply only in hyperphosphatu-
ric states. The formation of these calculi is occasionally
associated with the existence of renal tubular acidosis that
requires specific pharmacological treatment [39].
Struvite infectious calculi
Formation of these calculi is due to urinary infection, and
thus treatment involves pharmacological (antibiotic)
intervention [40]. To prevent recurrent infections, it is rec-
ommended that urinary pH values be maintained below
6.0. The dietary influence on urinary pH is discussed
above and summarized in Table 2.
Brushite calculi
The etiologic factors for these calculi are a urinary pH ≥
6.0, crystallization inhibitor (phytate and citrate) defi-
ciency and the existence of cavities with low urodynamic
efficacy. Dietary aspects linked to urinary pH and to the
control of urinary phytate and citrate are discussed above
and summarized in Table 2. As with hydroxyapatite cal-Nutrition Journal 2006, 5:23 http://www.nutritionj.com/content/5/1/23
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culi, these calculi are occasionally associated with tubular
acidosis and require pharmacological treatment.
Uric acid calculi
The most important risk factor for uric acid crystallization
and stone formation is a low urinary pH (below 5.5)
rather than high urinary uric acid excretion. By controlling
urinary pH, uric acid stone disease can be prevented, this
being one of the few urinary tract stones that can be suc-
cessfully dissolved in vivo. Thus, the recommendations for
uric acid stones involves liquid ingestion to produce daily
urine volumes above 2 L, urine alkalinization using citrate
or bicarbonate to maintain pH values between 6.2 and 6.5
[41], and a predominantly vegetarian diet. Maintaining a
Table 2: Relationship between urinary lithogen factors, types of renal calculi and dietary recommendations
Urinary Lithogen Factor Values of potentially lithogenic urinary biochemical 
parameters
Type of renal calculi Dietary recommendations
pH < 5.5 COM u
UA
COM/UA
CYS
Decrease habitual consumption of:
• Animal protein
Increase habitual consumption of:
• Citrus juices
• Soft-drinks
• Citric acid rich beverages
pH > 6.0 COM p
COM u
COD
HAP
COD/HAP
BRU
Decrease habitual consumption of:
• Vegetarian diet
• Citrus juices
• Soft-drinks
• Citric acid rich beverages
Calcium >170 mg/L
female: >250 mg/24 h
male: >300 mg/24 h
COD
HAP
COD/HAP
Increase habitual consumption of:
• Water intake (> 2 l/day)
Decrease habitual consumption of:
• Sodium
• Animal protein
Control:
• Vitamin D consumption
• Calcium supplements
Oxalate > 40 mg/24 h COM p
COM u
Decrease habitual consumption of:
• Oxalate rich foods (see Table 4)
• Ascorbic acid rich foods
(vitamin C intake greater than 2 g/day)
Citrate < 350 mg/24 h COM p
COM u
COD
HAP
COD/HAP
Increase habitual consumption of:
• Citrate rich foods
• Citric acid rich beverages
Phytate < 1 mg/24 h COM p
COM u
COD
BRU
Increase habitual consumption of:
• Phytate rich foods (see Table 3)
Urate > 650 mg/ml
female: > 600 mg/24 h
male: > 800 mg/24 h
UA
COM/UA
Decrease habitual consumption of:
• Purine rich foods (see Table 5)
• Alcoholic drinks
COM p: Calcium oxalate monohydrate papillary
COM u: Calcium oxalate monohydrate unattached (formed in renal cavities)
COD: Calcium oxalate dihydrate
COD/HAP: Calcium oxalate dihydrate/hydroxyapatite mixed
HAP: Hydroxyapatite
STR: Struvite infectious
BRU: Brushite
UA: Uric acid
COM/UA: Calcium oxalate/uric acid mixedNutrition Journal 2006, 5:23 http://www.nutritionj.com/content/5/1/23
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moderate consumption of animal protein, seafood (see
Table 5) and alcohol is also important [42]. Attention to
food portion size is also important [42]. However, if the
calculus is large or is located in cavities with very low uro-
dynamic efficacy, dissolution via urinary alkalinization is
very difficult, if not impossible. Treatment of this disorder
requires periodic control of urinary pH to avoid excess
alkalinization, which could cause other problems such as
hydroxyapatite lithiasis.
Calcium oxalate/uric acid mixed calculi
The main etiologic factors related to this type of renal cal-
culi are urinary crystallization inhibitor (citrate, phytate)
deficiency, urinary pH values below 5.5 and the presence
of renal cavities with low urodynamic efficacy. Due to the
double effect of citrate acting as a crystallization inhibitor
and increasing the urinary pH, citrate-rich foods or citrate
drugs are the basis of the most effective dietary or pharma-
cological treatment for these calculi [12]. In such cases,
the urinary pH must be controlled to avoid high values
that could induce hydroxyapatite formation.
Cystine calculi
Hypercystinuria is due to an autosomic recessive genetic
disorder that causes increased renal cystine excretion. The
hypercystinuria produces recurrent urolithiasis due to the
low solubility of cystine at low urinary pH values. The
prophylactic measures are based on a high hydric inges-
tion (at least 4 L of water daily) and urine alkalinization
using potassium citrate. Where these measures are not suf-
ficient, it is possible to use complementary pharmacolog-
ical treatment [43,44]. A low methionine diet has been
proposed to treat hypercystinuria. Methionine is an essen-
tial amino acid precursor of cysteine and cystine found in
protein from both animal (meat, fish and eggs) and vege-
table (soya, wheat and coconuts) sources. However, the
preventive efficacy of this diet has not been demonstrated.
Conclusion
Preventive measures for avoiding each type of renal calcu-
lus formation involve specific dietary considerations. The
main specific dietary guidelines relating to each lithogen
factor and type of renal calculus are summarized in Table
2. While there are specific dietary factors to be considered
for each calculus type, there is also a general list of dietary
measures that can be recommended in order to avoid any
renal calculus formation:
￿ Daily intake of a suitable liquid volume (minimum 2 L
water/day)
￿ Avoid strictly vegetarian diets
￿ Avoid excessive animal protein diets
￿ Avoid excessive salt (NaCl) consumption
Table 5: Main purine-rich foods
Purine Rich Animal Foods [46]
• Seafood
• Canned seafood: anchovies, sardines in oil, herrings.
• Fish roe
• Meat
• Organ meat: liver, kidney, sweetbreads
• Meat extracts, consomme, gravies.
Little is known about the precise identity and quantity of individual 
purines in most foods, especially when they are cooked or processed. 
In addition, the bioavailability of various purines contained in different 
foods varies substantially.
Table 4: Main oxalate-rich foods
Oxalate Rich Foods [20]
• Spinach
• Rhubarb
• Purslane
• Parsley
• Lambsquarters
• Chives
• Beet leaves
• Amaranth
• Green tea
• Chocolate
Unfortunately, a simple table is not adequate for comparing oxalate-
rich foods since: (a) the relative amounts of soluble and insoluble 
oxalate affect oxalate absorption, and simple percentage lists make no 
such distinctions, (b) the oxalic acid content can vary substantially 
depending on the environment in which the food source was grown, 
and (c) the amount of oxalate ingested is affected by the methods of 
food preparation and cooking, and the serving size.
Table 3: Main phytate-rich foods
Phytate Rich Foods [45]
• Cereal germ: i.e. corn germ
• Cereal bran: i.e. wheat cereal (100% bran)
• Whole cereals: i.e. wild rice
• Beans: i.e. whole bean, bean flours, bean protein products such as tofu
• Nuts: i.e. brazil nutsNutrition Journal 2006, 5:23 http://www.nutritionj.com/content/5/1/23
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￿ Avoid excessive vitamin C and/or vitamin D consump-
tion
￿ Consume phytate-rich products (natural dietary bran,
legumes and beans, whole cereals)
￿ Avoid exposition to cytotoxic substances (i.e., analgesics
abuse, residual pesticides, organic solvents and cytotoxic
drugs)
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